The treatment of acutely-ruptured intracranial aneurysms using stents or flow diverters in endovascular embolization is controversial for the past several years. Not all clinicians favor the use of stents and flow diverters for embolizing acutely-ruptured intracranial aneurysms. For one thing, the standardized approach using stents or flow diverters has not been established for embolization of acutely-ruptured intracranial aneurysms. For another, the use of stents or flow diverters may cause additional side effects in the acute phase of aneurysm rupture compared with the use of coils only. Nonetheless, because acutely-ruptured intracranial aneurysms may have unfavorable morphology for endovascular embolization, the use of stents or flow diverters is necessary.
Currently, the development of skills using stents or flow diverters for the treatment of acutely-ruptured intracranial aneurysms is not balanced. In some countries and regions, there are only a few cases of acutely-ruptured aneurysms which need to be treated with stents or flow diverters, whereas in other countries and regions like China with a large population and a great number of aneurysm patients, a lot of such patients need to be treated this way and the physicians or surgeons have accumulated a great deal of experience in using stents and flow diverters in the treatment of acutely-ruptured intracranial aneurysms. Thus, experiences should be promoted, and standardized embolization procedures should be established to improve the safety and efficacy of stents or flow diverters in embolizing acutely-ruptured aneurysms. Treatment of acutely-ruptured aneurysms in the acute phase is critical to the prognosis of these patients, and timely treatment for prevention of a secondary rupture of these aneurysms will promote further aggressive treatment, which is beneficial to the good prognosis of these patients.
Scientific papers on the following specific themes are welcome, including Original Research, Review, Brief Short Report, and Case Report on clinical and basic research:
• Comparison of the aneurysm re-rupture rate in the acute stage and the complication rate using stents or flow diverters in endovascular embolization of acutely-ruptured aneurysms;
• Safety of stents or flow diverters in embolization of ruptured aneurysms in the acute stage;
• Comparison of the incidence of ischemic events using different types of stents for assisting embolization of ruptured intracranial aneurysms in the acute stage;
• Periprocedural application of anticoagulant and anti-platelet agents when using stents or flow diverters for the treatment of ruptured intracranial aneurysms;
• Safety of flow diverters (FD) in the treatment of acutely ruptured intracranial aneurysms in the acute phase.
The treatment of acutely-ruptured intracranial aneurysms using stents or flow diverters in endovascular embolization is controversial for the past several years. Not all clinicians favor the use of stents and flow diverters for embolizing acutely-ruptured intracranial aneurysms. For one thing, the standardized approach using stents or flow diverters has not been established for embolization of acutely-ruptured intracranial aneurysms. For another, the use of stents or flow diverters may cause additional side effects in the acute phase of aneurysm rupture compared with the use of coils only. Nonetheless, because acutely-ruptured intracranial aneurysms may have unfavorable morphology for endovascular embolization, the use of stents or flow diverters is necessary.
Currently, the development of skills using stents or flow diverters for the treatment of acutely-ruptured intracranial aneurysms is not balanced. In some countries and regions, there are only a few cases of acutely-ruptured aneurysms which need to be treated with stents or flow diverters, whereas in other countries and regions like China with a large population and a great number of aneurysm patients, a lot of such patients need to be treated this way and the physicians or surgeons have accumulated a great deal of experience in using stents and flow diverters in the treatment of acutely-ruptured intracranial aneurysms. Thus, experiences should be promoted, and standardized embolization procedures should be established to improve the safety and efficacy of stents or flow diverters in embolizing acutely-ruptured aneurysms. Treatment of acutely-ruptured aneurysms in the acute phase is critical to the prognosis of these patients, and timely treatment for prevention of a secondary rupture of these aneurysms will promote further aggressive treatment, which is beneficial to the good prognosis of these patients.
Scientific papers on the following specific themes are welcome, including Original Research, Review, Brief Short Report, and Case Report on clinical and basic research:
• Comparison of the aneurysm re-rupture rate in the acute stage and the complication rate using stents or flow diverters in endovascular embolization of acutely-ruptured aneurysms;
• Safety of stents or flow diverters in embolization of ruptured aneurysms in the acute stage;
• Comparison of the incidence of ischemic events using different types of stents for assisting embolization of ruptured intracranial aneurysms in the acute stage;
• Periprocedural application of anticoagulant and anti-platelet agents when using stents or flow diverters for the treatment of ruptured intracranial aneurysms;
• Safety of flow diverters (FD) in the treatment of acutely ruptured intracranial aneurysms in the acute phase.
